Author

Jose Luis Martinez Lira

OpenAlex ID: A5113028893

Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial

2023 · Shannon N. Westin, Kathleen Moore, et al. · Journal of Clinical Oncology · 383

Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study

2025 · Hani M. Babiker, Vincent Picozzi, et al. · Journal of Clinical Oncology · 48

Bempegaldesleukin Plus Nivolumab Versus Sunitinib or Cabozantinib in Previously Untreated Advanced Clear Cell Renal Cell Carcinoma: A Phase III Randomized Study (PIVOT-09)

2024 · Nizar M. Tannir, Maria Nirvana Formiga, et al. · Journal of Clinical Oncology · 30

Works count: 3

Citation count: 460

H-index: 3

I10-index: 3